Squarepoint Ops LLC Replimune Group, Inc. Transaction History

Squarepoint Ops LLC

$62.8 Billion
Q3 2024

A detailed history of Squarepoint Ops LLC transactions in Replimune Group, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 19,564 shares of REPL stock, worth $250,223. This represents 0.0% of its overall portfolio holdings.

Number of Shares

19,564

Holding current value

$250,223

% of portfolio

0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$8.09 - $11.23 $158,272 - $219,703	19,564 New	19,564 $214,000
Q4 2023 Feb 14, 2024	SELL	$6.75 - $16.18 $6,014 - $14,416	-891 Reduced 4.79%	17,716 $149,000
Q2 2023 Aug 14, 2023	SELL	$15.65 - $24.1 $840,498 - $1.29 Million	-53,706 Reduced 74.27%	18,607 $432,000
Q1 2023 May 15, 2023	SELL	$17.48 - $29.09 $81,229 - $135,181	-4,647 Reduced 6.04%	72,313 $1.28 Million
Q4 2022 Feb 14, 2023	BUY	$17.09 - $27.91 $1.32 Million - $2.15 Million	76,960 New	76,960 $2.09 Million
Q2 2022 Aug 15, 2022	SELL	$13.32 - $19.98 $155,524 - $233,286	-11,676 Reduced 27.08%	31,434 $549,000
Q1 2022 May 16, 2022	BUY	$15.24 - $29.75 $656,996 - $1.28 Million	43,110 New	43,110 $732,000
Q3 2021 Nov 15, 2021	SELL	$28.98 - $39.54 $1.11 Million - $1.52 Million	-38,421 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$28.5 - $39.37 $84,616 - $116,889	2,969 Added 8.37%	38,421 $1.48 Million
Q1 2021 May 17, 2021	SELL	$30.22 - $45.57 $1.06 Million - $1.6 Million	-35,070 Reduced 49.73%	35,452 $1.08 Million
Q4 2020 Feb 16, 2021	BUY	$23.5 - $52.65 $930,388 - $2.08 Million	39,591 Added 128.0%	70,522 $2.69 Million
Q3 2020 Nov 16, 2020	BUY	$18.85 - $27.0 $142,656 - $204,336	7,568 Added 32.39%	30,931 $712,000
Q2 2020 Aug 14, 2020	SELL	$9.76 - $25.95 $309,997 - $824,223	-31,762 Reduced 57.62%	23,363 $581,000
Q1 2020 May 15, 2020	SELL	$8.9 - $19.08 $297,776 - $638,378	-33,458 Reduced 37.77%	55,125 $550,000
Q4 2019 Feb 14, 2020	BUY	$11.61 - $17.21 $775,362 - $1.15 Million	66,784 Added 306.36%	88,583 $1.27 Million
Q3 2019 Nov 14, 2019	BUY	$10.01 - $16.87 $56,045 - $94,455	5,599 Added 34.56%	21,799 $303,000
Q2 2019 Aug 14, 2019	BUY	$12.51 - $17.28 $202,662 - $279,936	16,200 New	16,200 $237,000

Others Institutions Holding REPL

# of Institutions

149

Shares Held

68M

Call Options Held

52.3K

Put Options Held

80.3K

Baker Bros. Advisors LP New York, NY

11M
Shares

$141 Million
1.3% of portfolio
Price T Rowe Associates Inc Baltimore, MD

9.88M
Shares

$126 Million
0.01% of portfolio
Fcpm Iii Services B.V. Naarden, P7

4.87M
Shares

$62.2 Million
9.16% of portfolio
Redmile Group, LLC San Francisco, CA

4.78M
Shares

$61.2 Million
3.43% of portfolio
Black Rock Inc. New York, NY

4.71M
Shares

$60.3 Million
0.0% of portfolio

View Full List

About Replimune Group, Inc.

Ticker REPL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,306,700
Market Cap $631M
Description
Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...

More about REPL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account